| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Sera from 61 Indian patients with visceral leishmaniasis caused by infection with Leishmania donovani were tested for the presence of T helper 1 (Th1) cell-(interferon-
[IFN-]) and Th2 cell-associated cytokines (interleukin-4 [IL-4] and IL-10). The IFN- activity was detected in 53%, IL-4 in 84%, and IL-10 in 56% of patient samples. Sera from 10 healthy Indian controls showed detectable IFN- in 90%, IL-4 in 10%, and IL-10 in 20%; corresponding percentages for sera from eight healthy American controls were 100%, 12%, and 0%, respectively. Quantitative data for the 61 patients compared with the 10 Indian controls indicated comparable mean levels of IFN-, but three- and 13-fold increases in IL-10 and IL-4, respectively. Undetectable IFN- activity, observed in 47% of patients, was associated with the presence IL-4 alone or in combination with IL-10 but not with IL-10 alone. In patients who had failed prior therapy (n = 29) compared with previously untreated patients (n = 32), IFN- levels were 67% lower and IL-4 levels were two-fold higher; IL-10 activity was comparable. These results using peripheral blood support the presence of a suppressive Th2 cell-associated immune response in symptomatic Indian kala-azar and point to a possible role for IL-4.
This article has been cited by other articles:
|
|
 |
|
  A. Banerjee, M. De, and N. Ali Complete Cure of Experimental Visceral Leishmaniasis with Amphotericin B in Stearylamine-Bearing Cationic Liposomes Involves Down-Regulation of IL-10 and Favorable T Cell Responses J. Immunol., July 15, 2008; 181(2): 1386 - 1398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. McFarlane, C. Perez, M. Charmoy, C. Allenbach, K. C. Carter, J. Alexander, and F. Tacchini-Cottier Neutrophils Contribute to Development of a Protective Immune Response during Onset of Infection with Leishmania donovani Infect. Immun., February 1, 2008; 76(2): 532 - 541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Saha, S. Mondal, R. Ravindran, S. Bhowmick, D. Modak, S. Mallick, M. Rahman, S. Kar, R. Goswami, S. K. Guha, et al. IL-10- and TGF-beta-Mediated Susceptibility in Kala-azar and Post-kala-azar Dermal Leishmaniasis: The Significance of Amphotericin B in the Control of Leishmania donovani Infection in India J. Immunol., October 15, 2007; 179(8): 5592 - 5603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. L. K. Wong, K.-F. Chan, B. A. Burkett, Y. Zhao, Y. Chai, H. Sun, T. H. Chan, and L. M. C. Chow Flavonoid Dimers as Bivalent Modulators for Pentamidine and Sodium Stiboglucanate Resistance in Leishmania Antimicrob. Agents Chemother., March 1, 2007; 51(3): 930 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. V Piscopo and C. Mallia Azzopardi Leishmaniasis. Postgrad. Med. J., February 1, 2007; 83(976): 649 - 657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T V Piscopo and A C Mallia Leishmaniasis. Postgrad. Med. J., October 1, 2006; 82(972): 649 - 657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. M. Roberts Current understandings on the immunology of leishmaniasis and recent developments in prevention and treatment Br. Med. Bull., July 17, 2006; 75-76(1): 115 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Rosas, A. A. Satoskar, K. M. Roth, T. L. Keiser, J. Barbi, C. Hunter, F. J. de Sauvage, and A. R. Satoskar Interleukin-27R (WSX-1/T-Cell Cytokine Receptor) Gene-Deficient Mice Display Enhanced Resistance to Leishmania donovani Infection but Develop Severe Liver Immunopathology Am. J. Pathol., January 1, 2006; 168(1): 158 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Breton, M. J Tremblay, M. Ouellette, and B. Papadopoulou Live Nonpathogenic Parasitic Vector as a Candidate Vaccine against Visceral Leishmaniasis Infect. Immun., October 1, 2005; 73(10): 6372 - 6382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. W. Murray, K. C. Flanders, D. D. Donaldson, J. P. Sypek, P. J. Gotwals, J. Liu, and X. Ma Antagonizing Deactivating Cytokines To Enhance Host Defense and Chemotherapy in Experimental Visceral Leishmaniasis Infect. Immun., July 1, 2005; 73(7): 3903 - 3911. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Saha, T. Mazumdar, K. Anam, R. Ravindran, B. Bairagi, B. Saha, R. Goswami, N. Pramanik, S. K. Guha, S. Kar, et al. Leishmania Promastigote Membrane Antigen-Based Enzyme-Linked Immunosorbent Assay and Immunoblotting for Differential Diagnosis of Indian Post-Kala-Azar Dermal Leishmaniasis J. Clin. Microbiol., March 1, 2005; 43(3): 1269 - 1277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ravindran, K. Anam, B. C. Bairagi, B. Saha, N. Pramanik, S. K. Guha, R. P. Goswami, D. Banerjee, and N. Ali Characterization of Immunoglobulin G and Its Subclass Response to Indian Kala-Azar Infection before and after Chemotherapy Infect. Immun., February 1, 2004; 72(2): 863 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. W. Murray, C. M. Lu, S. Mauze, S. Freeman, A. L. Moreira, G. Kaplan, and R. L. Coffman Interleukin-10 (IL-10) in Experimental Visceral Leishmaniasis and IL-10 Receptor Blockade as Immunotherapy Infect. Immun., November 1, 2002; 70(11): 6284 - 6293. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
